A Parallel Arm Phase 1b/2a Study of DKN-01 as Monotherapy or in Combination With Docetaxel for the Treatment of Advanced Prostate Cancer With Elevated DKK1
Clinical trial NCT03837353 · TERMINATED
Trial details
- NCT number
- NCT03837353
- Sponsor
- NYU Langone Health
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-04-01
- Primary completion
- 2022-07-19
- Enrollment
- 18
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.